GSK (GSK) stock gains as the company's Q1 2025 results beat Street forecasts thanks to its Specialty Medicines business. Read ...

British drugmaker GSK said it was "well positioned" to respond to any potential impact from sector-specific tariffs if they ...

British drugmaker GSK said on Wednesday it was "well positioned" to respond to any potential financial impact from ...

An experimental Boehringer Ingelheim drug achieved “unprecedented” benefits in patients with an advanced form of lung cancer ...